Sponsor pipeline

Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. clinical trial pipeline

Get alerts when Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.'s trials change

3 active trials 2 recruiting 6 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 1
1
Phase 1/2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06931990 A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158… Atopic Dermatitis (AD) Recruiting 2026-08-27
NCT06932003 A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158… Hidradenitis Suppurativa (HS) Recruiting 2026-08-27
Phase 1
NCT07624214 Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors Non-small Cell Lung Cancer (NSCLC) Not Yet Recruiting 2026-06-03

Disease areas by active trials

Get alerts when Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free